MSB 7.69% $1.19 mesoblast limited

DREAM HF Trial Video, page-19

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    Peer review due 27th - Decrease in strokes over
    controls now higher than 65%
    .


    What”s that you say @regina,dp ?

    …. those results are in fact from a phase 3 RCT undertaken over a 5 year period in the USA ….


    ….. those results are from just one single dose of Rexlemestrocel-L and were achieved over and above the current SOC …..


    ….. but how can this be @reginaldp when people even as recently as this morning are saying Mesoblast don’t do ‘controlled trials’ ? …. too funny and now I guess we can all look forward to the self proclaimed medical experts on here in the lead up to the JACC publication telling us all how these results are flawed in some way or (my favourite) are post hoc analysis etc as they try and discount just how remarkable the results really are …. they’re real results people taken from real RCT phase 3 human trial data - just sayin’


    … AND THESE RESULTS WERE ACHIEVED FROM ONE SINGLE DOSE OF REXLEMESTROCEL-L
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.